Tag Archives: Stocks

Aurora Cannabis to Buy Rival to Create World's Most Valuable Weed Firm

Aurora Cannabis to Buy Rival to Create World’s Most Valuable Weed Firm

Canada’s No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country’s legalization of recreational marijuana use later this year.

Canada's Small Financial Firms Get Buzz From Weed Stocks

Canada’s Small Financial Firms Get Buzz From Weed Stocks

Investors are betting Canada’s smaller financial firms could see a jump in revenues after they helped fund marijuana companies ahead of the country’s planned legalization of the drug this year.

Why Aurora Cannabis Inc. Will Outperform Canopy Growth Corp. in 2018

Why Aurora Cannabis Inc. Will Outperform Canopy Growth Corp. in 2018

Aurora Cannabis Inc. (TSX:ACB) and Canopy Growth Corp. (TSX:WEED) are the two frontrunners in the rapidly emerging Canadian cannabis scene, but will these two powerhouses play leapfrog as legalization day comes and goes?

Canadian Marijuana Producers End Rally as U.S. Set to Tighten Enforcement

Canadian Marijuana Producers End Rally as U.S. Set to Tighten Enforcement

Canadian cannabis stocks fell on Thursday after the U.S. government said it would resume enforcement of federal laws banning marijuana in states that had legalized pot, disrupting a seven-day rally that boosted shares to record highs.

Pot Stocks Soar as California Gets Ready to Get High

Pot Stocks Soar as California Gets Ready to Get High

Marijuana companies are higher than ever as California rolls toward recreational legalization. The BI Canada Cannabis Competitive Peers index is having its best day ever as Californians prepare to light up, or eat up, marijuana products starting Jan. 1 at 12 a.m.

Canadian Regulators Ask CanniMed to Abandon Rights Plan Against Aurora Bid

Canadian Regulators Ask CanniMed to Abandon Rights Plan

Medical marijuana maker CanniMed Therapeutics Inc (CMED.TO) should withdraw a shareholder rights plan adopted to fend off a hostile bid from larger rival Aurora Cannibis Inc ABC.TO, two Canadian regulators have ruled.

5 Reasons Cannabis Stocks Were on Fire in 2017

5 Reasons Cannabis Stocks Were on Fire in 2017

You might be wondering what’s behind the big rally in cannabis stocks? While a generally bullish market has certainly helped, there are five other considerably more prominent reasons behind the rally in marijuana stocks in 2017.

Marijuana Index Gains Continue As Pot Stocks Anticipate Prohibition Repeal

Marijuana Index Gains Continue As Pot Stocks Anticipate Prohibition Repeal

It was another big day of gains on Tuesday for the North American Marijuana Index, even as some investors anxiously wait for the Fed to announce an interest rate hike in the next 24 hours.

Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group

Canada’s Aurora Cannabis Boosts Stake in Australia-Based Cann Group

Canada’s Aurora Cannabis Inc (ACB.TO) said on Monday it increased its stake in Australia-based Cann Group Ltd (CAN.AX) to 22.9 percent from 19.9 percent, its latest move to expand in the cannabis industry.

How to Buy Marijuana Stocks Quickly and Easily With This New Fund

How to Buy Marijuana Stocks Quickly and Easily With This New Fund

The first U.S. exchange-traded fund, ETF, to focus on marijuana stocks is launching Dec. 26 — days before California legalizes recreational cannabis use on January 1.

Canada Weed Stocks Come Off High as Challenges Loom Before Legalization

Canada Weed Stocks Come Off High as Challenges Loom Before Legalization

Canada’s weed stocks, which have surrendered some of the potent gains that pushed them to record highs this month, face a bumpy ride in 2018 that could purge smaller players, as the country moves to allow recreational use of cannabis in July.

Can Any Other Cannabis Stock Measure Up to Canopy Growth Right Now?

Can Any Other Cannabis Stock Measure Up to Canopy Growth?

Shares of Canopy Growth Corp. (TSX:WEED) have climbed a stunning 53.8% month over month as of close on November 1. With all of this in mind, has Canopy established itself as the premier cannabis stock for Canadians?

Making the Case for Cannabis as an Ethical Investment

Making the Case for Cannabis as an Ethical Investment

The high-growth industry certainly offers terrific prospects that would be envied by many tech stocks. However, a big hurdle for some investors is investing in “sin stocks,” or what could be perceived as unethical industries and businesses.

Are Canada’s Licensed Marijuana Producers at Risk of Becoming Delisted?

Are Canada’s Licensed Marijuana Producers at Risk of Becoming Delisted?

Marijuana stocks were down sharply in Tuesday’s trading as Toronto Stock Exchange operator TMX Group Limited suggested the exchange is going to start cracking down on marijuana producers engaging in illegal activities south of the border.

Shares of Canada's Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canada’s Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.

Toronto Stock Exchange May Delist Marijuana Firms With US Operations

Toronto Stock Exchange May Delist Marijuana Firms With US Operations

Canada’s TMX Group Ltd (X.TO), operator of the Toronto Stock Exchange, said on Monday that it might delist stocks of marijuana companies with interests in the United States, where their operations are illegal under federal law.

Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion

Investing in Marijuana: Cannabis Industry Raises Hit $1.8 Billion

Despite strong opposition from former White House Press Secretary Sean Spicer and Attorney General Jeff Sessions, and the overall limitations imposed by federal illegality in the U.S., 2017 is shaping up to be a great year for the North American cannabis industry.

3 Ways to Avoid Marijuana Stock Investment Scams

3 Ways to Avoid Marijuana Stock Investment Scams

Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.

Big Weed is on Board With Trudeau’s Marijuana Tax Plan

Big Weed is on Board With Trudeau’s Marijuana Tax Plan

Canada’s biggest medical cannabis producers are seeing their stock prices rise after the federal government announced a plan to levy a one dollar per gram tax on recreational marijuana sales.

Zynerba's Stock on a High as Cannabis-Based Drug Succeeds in Trial

Zynerba’s Stock on a High as Cannabis-Based Drug Succeeds in Trial

Zynerba Pharmaceuticals Inc said on Thursday its cannabis-based gel met the main goal in a mid-stage study of patients with Fragile X syndrome, a genetic disorder that causes learning disabilities in adolescents and children.

Why More Medical Marijuana IPOs Are Coming and Why You Should Avoid Them

Why More Medical Marijuana IPOs Are Coming

Almost three months after the initial public offering (IPO) of MedReleaf Corp. (TSX:LEAF), shares have yet to do much in either direction. The company, which came to market in what was then described as a “botched IPO,” fell quickly out of the gate from its IPO price.

The 1 Marijuana Stock That Can Thrive, Even If Jeff Sessions Cracks Down

The 1 Marijuana Stock That Can Thrive, Even If Jeff Sessions Cracks Down

Undoubtedly, a reversal in the federal government’s laxness on pot would be terrible news for marijuana stock investors, but not every last company would be decimated. One marijuana stock could still thrive, even with Jeff Sessions waving the metaphorical sword at the pot industry: Scotts Miracle-Gro.

Where Are Canadian Cannabis Stocks Headed From Here?

Where Are Canadian Cannabis Stocks Headed From Here?

With prices for many major Canadian cannabis stocks such as Canopy Growth Corp., Aphria Inc., and Aurora Cannabis Inc. trading sideways over the past few months, investors are now wondering which direction stocks will move from here, and what the long-term play with this industry is overall.

Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors

Why Canopy Growth Corp. Will Become Great Again in the Eyes of Investors

Canopy Growth Corp. (TSX:WEED) was the first cannabis stock to the market and quickly captured the attention of traders and risk-taking growth investors alike. As a result, shares of Canopy skyrocketed 300% in a span of just a few months last year.

Pixabay / rawpixel / CC0 Public Domain

Better Know a Marijuana Stock: Cronos Group

Whereas most weed businesses are working harder than ever to increase their grow capacity, Cronos Group is a company that’s trying to work smarter. Based in Canada, Cronos Group is an investment firm that primarily invests in Canadian-based pot companies involved in Canada’s medical-marijuana industry.

Marijuana Firm Says TMX Trade Shift Would Undermine System

Marijuana Firm Says TMX Trade Shift Would Undermine System

Any move by the Toronto Stock Exchange owner to stop settling trades for marijuana companies with U.S. operations would undermine the market’s regulatory system, according to one Canadian pot company.

Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?

Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?

TMX Group Ltd. (TSX:X), the operator of the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), has reportedly been speaking with regulators to figure out what will happen to Canadian marijuana producers with assets in the U.S.

TMX Says Lower Trading Volume Mostly Due to Avoidance of Pot Stocks

TMX Says Lower Trading Volume Mostly Due to Avoidance of Pot Stocks

TMX Group Ltd’s CEO on Thursday brushed off signs that the grip of Canada’s dominant stock exchange operator on overall trading volumes was slipping, saying recent market share losses were mostly due to its rejection of certain listings.

The 1 Word in GW Pharmaceuticals' Q3 Update That Disappointed Investors

The 1 Word in GW Pharmaceuticals’ Q3 Update That Disappointed Investors

When GW Pharmaceuticals announced its fiscal third-quarter results on Monday, the company provided plenty of information about its performance during the quarter. However, it wasn’t any of the numbers in the update that caused this decline. Instead, one word caused investors’ disappointment.


Page 1 of 512345
Top